As funeral costs rise, many grieving families face a difficult financial decision. This article explores the realities of funeral loans, alternative funding sources, and the long-term implications of taking on debt during a time of loss.
Brookfield Business Partners reported a robust 2025, generating over $2 billion from asset sales, reducing debt, and making strategic acquisitions. The firm is on the cusp of a major corporate restructuring into a single listed entity, aiming to boost liquidity and investor appeal in a shifting global landscape.
Market sentiment on prediction platform Myriad has turned bearish for the first time in two months, with traders placing nearly equal odds on Bitcoin's plunge to $69,000 or a rally to $100,000 as U.S. political uncertainty fuels extreme volatility.
For investors seeking sustained growth over decades, two exchange-traded funds stand out for their proven track records and strategic holdings in the world's leading companies.
As the Trump administration ratchets up pressure on Tehran, experts warn that military action aimed at halting Iran's nuclear program could backfire, potentially accelerating proliferation worldwide and unraveling the non-proliferation regime.
Shares of Corcept Therapeutics plunged 16% after a corrected FDA letter disclosed the agency had repeatedly cautioned the company against filing its application for a Cushing's syndrome drug, which was later rejected over efficacy and safety concerns.
The Hartford Financial Services Group reported stellar full-year 2025 results, with core earnings reaching $3.8 billion and a return on equity of 19.4%. Strong performance across Business, Personal, and Employee Benefits insurance segments, coupled with strategic investments in AI and digital capabilities, positions the insurer for sustained market leadership.
ExxonMobil reported a 14% year-on-year decline in fourth-quarter net profit, pressured by lower crude prices and chemical margins. Despite the quarterly drop, the energy giant highlighted record production levels, robust cash flow, and continued heavy returns to shareholders as evidence of its strengthened operational foundation.
In a landmark shift, Venezuela's parliament has passed sweeping reforms to its hydrocarbons law, aiming to lure private capital into its crippled oil industry. The move, backed by a new U.S. license, signals a potential turning point for the nation's economy.
Since its spin-off from GE Aerospace, GE Vernova's stock has soared over 400%. While its position in gas, wind, and next-gen nuclear power is formidable, sky-high valuations give even growth investors pause.
CareDx CEO John Hanna sold over 19,000 shares under a pre-arranged trading plan, a move that comes as the transplant diagnostics firm posts strong revenue growth but continues to navigate a challenging stock market environment.
Despite reporting strong quarterly earnings, Microsoft shares suffered one of their worst single-day drops in history as investors balked at soaring capital expenditures for AI infrastructure and signs of slowing growth in its Azure cloud division.
Investor Kevin O'Leary argues that rigid return-to-office policies are a competitive disadvantage, pushing high performers toward flexible employers and leaving companies with a diminished talent pool.
The automotive safety giant posted historic sales and cash flow in 2025, powered by explosive growth with Chinese automakers and in India. While navigating a softer production forecast and tariff headwinds, management projects margin expansion for 2026.
Selective Insurance Group reported robust profitability and investment returns for 2025, driven by disciplined underwriting actions. While celebrating an 18% book value growth, management detailed significant reserve strengthening in commercial auto and outlined a confident outlook for 2026, the year of its centennial.
Allegro MicroSystems (ALGM) has restructured its credit facilities, securing $285 million in new term loans maturing in 2030. The move provides the semiconductor firm with fresh capital for corporate initiatives as it navigates a capital-intensive sector while maintaining a premium market valuation.
The trading platform's launch of commission-free event contracts for the Big Game has sparked interest, but its shares continue to struggle, raising questions about its valuation and growth narrative.
Chemed Corporation (NYSE: CHE) has seen its share price soften recently, reigniting investor debate over whether the healthcare services provider is now undervalued. With the stock trading around $430, a significant gap exists against some fair value estimates, even as operational challenges in its VITAS and Roto-Rooter segments loom.
A revised price target for Invesco Mortgage Capital (IVR) is prompting investors to reassess the mortgage REIT's trajectory amid evolving interest rate expectations and housing market dynamics.
Accent Group's strategic partnership with UK retail giant Frasers, including a planned rollout of Sports Direct stores in Australia, is drawing investor focus as it promises to reshape the footwear retailer's earnings profile. The move comes amid volatile share price performance, raising questions about the company's current valuation.
